NCT01376180已完成不适用
Drug Use Investigation for LAMICTAL
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 3,000
- 主要终点
- The number of adverse events in Japanese subjects with epilepsy treated with lamotrigine tablet
研究概览
简要总结
The purpose of this study is to grasp actual status of usage of lamotrigine tablet and to collect information for using lamotrigine tablet effectively and safely as well as to grasp onset status of adverse events in pediatric subjects, geriatric subjects, pregnant women, subjects with poor renal and hepatic functions.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects with epilepsy having the following seizure types.
- •Partial seizures (including secondary generalized seizures)
- •Tonic-clonic seizures
- •Generalized seizures of Lennox-Gastaut syndrome
排除标准
- 未提供
研究组 & 干预措施
Subjects prescribed lamotrigine tablet
Subjects with epilepsy prescribed lamotrigine tablet during study period
干预措施: Lamotrigine (Drug)
结局指标
主要结局
The number of adverse events in Japanese subjects with epilepsy treated with lamotrigine tablet
时间窗: 6 months
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Special Drug Use Investigation for LAMICTAL® (Long Term)EpilepsyNCT01863602GlaxoSmithKline850
已完成
不适用
Observational Study of LamotrigineEpilepsyNCT00299793Northwell Health60
已完成
不适用
Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"Type 2 Diabetes Mellitus Who Have Been Examined at a Medical InstitutionNCT01945216Takeda3,317
进行中（未招募）
不适用
Special drug-use survey of Tarlige tablet (evaluation of safety in long-term use)JPRN-jRCT2031200212Matsuoka Yomei900
已完成
不适用
Drug Use Investigation for IMIGRAN TabletMigraine DisordersNCT01376141GlaxoSmithKline3,571